Formulation and Evaluation of Solid Dispersion Chitosan Tablet from Whiteleg Shrimp (Litopenaeus vannamei) Using PVP K-30 As a Carriers by Imtihani, Hilya Nur et al.
Borneo Journal of Pharmacy http://journal.umpalangkaraya.ac.id/index.php/bjop/article/view/1557  
Vol 4 Issue 1 February 2021 DOI: https://doi.org/10.33084/bjop.v4i1.1557 




Indonesia is a maritime country with considerable 
potential as a producer of marine animals, primarily 
natural sources of chitin, such as shrimp and crab shells1. 
Shrimp shell contains 25-40% protein, 45-50% calcium 
carbonate, and 15-30% chitin, but the amount of the 
content depends on the type of shrimp2. In this study, 
chitin was extracted from whiteleg shrimp (Litopenaeus 
vannamei) because it was ranked first of the five primary 
commodities trafficked in the country (between 
provinces) as much as 72.81%. This fact means that a lot 
of shrimp production has been distributed to regions 
between provinces. East Java is the second-highest 
province after Bengkulu (37.84%) as an L. vannamei 
supplier with 24.49%3. However, chitin is not soluble in 
water, so its use is limited. By using a strong base 
(deacetylation process) into chitosan, hydrolyzing chitin 
has better chemical properties4. 
Chitin can be transformed into chitosan, which has 
prospects in biomedical trends5. Besides being known as 
a drug carrier, chitosan is also known as an active agent 
for anticholesterol. The previous research reported that in 
vitro, chitosan could bind cholesterol by 63.5% to prevent 
an increase in cholesterol levels6. A study stated that 
administering 30 chitosan tablets at a dose of 45 mg of 
chitosan/tablet three times a day can reduced cholesterol 
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Whiteleg shrimp (Litopenaeus vannamei) on the market are processed 
or sold only to take part in the meat. The head, shell, and tail are 
thrown away without any prior processing. Underutilized waste 
causes environmental problems. An alternative to overcome this 
environmental disturbance phenomenon is to utilize shrimp shells 
containing chitin and subsequently transformed into chitosan that can 
be applied in various fields. Chitosan has poor solubility in water but 
high permeability; thus, improve bioavailability is accomplished by 
making solid dispersions. This study aims to formulate and evaluate 
the solid dispersion tablet using chitosan extract from L. vannamei as 
an active agent with PVP K-30 as a carrier. The formulation divided 
into three groups, that was F1 (chitosan : PVP K-30 = 1 : 1 solid 
dispersion), F2 (chitosan : PVP K-30 = 1 : 3 solid dispersion), and F3 
(pure chitosan). The result of chitosan solid dispersion was molded 
into tablets by the direct compression method. The tablets were 
evaluated by weight and size uniformity, hardness, friability, and 
disintegration time. All the formulas by weight and size uniformity as 
well as disintegration time fulfill the requirements. The hardness of 
the tablets from F3 with 4,275 kg was the best from F1 and F2. By 
statistic analytical from weight uniformity, hardness and 
disintegration time give significant difference with sig. <0.05. 
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levels7. However, chitosan has poor solubility in water, 
but the permeability is high, so efforts are needed to 
increase the solubility so that chitosan can be used as an 
anticholesterol drug. 
Solid dispersion is a method of making a dispersion 
system where drugs with low solubility in water will be 
dispersed into a water-soluble carrier to increase the 
solubility and dissolution of the drug8,9. The carrier used 
in this solid dispersion formulations is PVP K-30 because 
its polymer is hydrophilic, has very good water 
solubility, and can be used as a stabilizer10. The results of 
the chitosan solid dispersion formulation were hence 
made into direct compression tablets. The direct 
compression method was chosen because it is the most 
energy-efficient, fastest, and most economical way to 
produce tablets11. Based on this background, research 
will be carried out to formulate and evaluate the solid 
dispersion tablet using chitosan extract from L. vannamei 
as an active agent with PVP K-30 as a carrier in the ratio 
of 1 : 1 and 1 : 3 (Chitosan : PVP K-30). Evaluation of solid 
dispersion tablets is weight and size uniformity, 
hardness, friability, and disintegration time. 
 
MATERIALS AND METHODS 
Materials 
The L. vannamei was obtained from Pasuruan, East Java. 
The reagents used include HCl (Merck), NaOH (Merck), 
ninhydrin solution, distilled water (Brataco), PVP K-30 




1. Pre-treatment: The shell of L. vannamei was washed 
with running water and boiled for 15 minutes. The 
clean shell dried in the sunlight for 2 x 24 hours or 
until dry. The dried shell was blended with a blender 
until smooth and sieved with 100 mesh12. 
2. Demineralization: 100 g of the sifted shell of L. 
vannamei powder was weighed. 1M HCl solution 
was added while stirring with a magnetic stirrer with 
a speed of 200 rpm at 75°C for an hour. The solution 
was filtered with filter paper, and rinse the residue 
with distilled water until neutral pH. The residue was 
dried in the oven at 60°C for 24 hours or until it dries12. 
3. Deproteination: The dry solids demineralized were 
dissolved in 3.5% NaOH while stirring with a 
magnetic stirrer speed of 450 rpm at 65°C for 2 hours. 
The mixed solution was filtered with filter paper, and 
the residue was rinsed with distilled water until 
neutral pH. The residue was dried in the oven at 65°C 
for 24 hours or until it dries13. 
4. Deacetylation: Chitin from the deproteination was 
dissolved in 60% NaOH with ratio of 1 : 20 (w/v). The 
solution was stirred using a magnetic stirrer with 250 
rpm at 100°C for 4 hours. The mixed solution was 
filtered with filter paper. The residue was rinsed with 
distilled water until neutral pH and dried in an oven 
at 65°C for 24 hours or until it dries13,14. 
Chitosan evaluation 
Chitosan from synthesis was evaluated by organoleptic, 
yield, ninhydrin, and deacetylation degrees15,16. 
Solid dispersion procedure 
Chitosan and PVP K-30 was prepared in a ratio of 1 : 1 
and 1 : 3 (w/w). Chitosan was dissolved in 2% acetic acid 
(1 : 50) and stirred until it dissolves. PVP K-30 as a carrier 
was dissolved in (1 : 5) of 2% acetic acid solvent. Both 
solutions were mixed and evaporated above the water 
bath in a fume hood at 50-60°C until a precipitate was 
formed. The evaporation results were dried in the oven 
at 50°C for 1-2 hours or until it dries. The masses were 
crusted and sieved with 100 mesh sieves17. 
Tablets formulation 
Chitosan and PVP K-30 solid dispersion were prepared 
as well as weighed magnesium stearate, talk, and Avicel 
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PH 102 which was sieved with a mesh 100 sieve. That 
ingredient was mixed until homogeneous. Therefore, the 
tablets were compressed by the direct compression 
method. The tablets were observed and evaluated 
(uniformity in tablet weight and size, hardness, friability, 
and disintegration time)18. 
Experimental design 
The dose of chitosan as an active pharmaceutical 
ingredient (API) was 45 mg/tablet by the study of Jing et 
al.7. The formulas were divided into three groups (n = 3). 
The division of groups was arranged based on different 
materials as follows: 
1. F1 (control): Pristine chitosan as an active agent 
2. F2: Chitosan : PVP K-30 solid dispersion (1 : 1) 
(w/w). 
3. F3: Chitosan : PVP K-30 solid dispersion (1 : 3) 
(w/w). 
 
RESULTS AND DISCUSSION 
The formulation of solid dispersion tablets of chitosan 
extract from L. vannamei shell with PVP K-30 as a carrier 
of solid dispersion started with chitosan synthesis. From 
these stages, the chitosan obtained was then evaluated. 
The evaluation results were presented in Table I, while 
the chitosan powder appearance was presented in Figure 
1. 
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Figure 1. Chitosan powder F1 
 
From the evaluation of chitosan, it could be stated that 
chitosan had fulfilled all the evaluation requirements that 
exist from organoleptic (shape and color) which was 
creamy white19, deacetylation degree with 74.02% 
(>70%)20, and ninhydrin test with positive purple6. The 
yield test was a chitosan recovery test compared to the 
amount of shrimp shell used. The yield test result was 
16.21%, which was higher than the previous research 
result which was 15.26%.21.  
Hence, the chitosan was made into a solid dispersion 
system to increase chitosan solubility, except for F1 as 
control, and then formulated into tablet preparations as 
showed in Table II. The direct compression method 
carried out the tablet formulation and used additional 
ingredients to formulate the direct compression tablet 
method with good flow and compactibility, as shown in 
Figure 2. 
Table II. Formulation of solid dispersion tablet chitosan 
Material Use F1 (control) F2 (1 : 1) F3 (1 : 3) 
Chitosan  Active 
agent 
45 mg 45 mg 45 mg 
PVP K-
30 
Carrier - 45 mg 135 mg 
Mg 
Stearate 
Lubricant 1% 1% 1% 
Talk Glidant 2% 2% 2% 
Avicel 
PH 102 
Diluent ad 350 mg ad 350 mg ad 350 mg 
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Figure 2. Solid dispersion of F2 (left) and F3 (right) 
 
Evaluation of dispersion tablet started with weight 
uniformity. The result from this evaluation was all three 
formulas had good uniformity and none of the tablets out 
from A and B column18. The statistical analysis with one-
way ANOVA shows that sig. 0,000. Moreover, the LSD 
(Least Significant Difference) shows that F2 and F3 
significantly different from F1. Therefore, a solid 
dispersion tablet made an impact on chitosan without 
solid dispersion making. 
The uniformity size from F1, F2, and F3 fulfill the 
requirements18, which was ⅓ T < D < 3T. T was the 
thickness, and D was the diameter.  F1 was 1.25 < 11.14 < 
11.25;  F2 was 1.27 < 11.29 < 11.40; and F3 was 1.27 < 11.09 
< 11.40. The statistical analysis with Kruskal-Wallis from 
diameter shows that asymp. Sig. 0.000. Furthermore, 
Mann-Whitney Test shows that all the formulas had 
significantly different from each other. However, the 
Levene Test's statistical analysis from tablet thickness 
shows that the result was not significantly different from 
each other. 
The tablets were also tested using the hardness tester. The 
requirement for tablet hardness was 4-8 kg22. The average 
hardness from F1 was 1.975 ± 0.444 kg; F2 was 1.175 ± 
0.494 kg; and F3 was 4.275 ± 1.482 kg. It shows that F3 was 
the best hardness character and the one hardness that fills 
requirements22. F3 was chitosan without made solid 
dispersion. Development formula from direct 
compression tablets was required to generate good 
hardness tablet quality. The statistical analysis with 
Kruskal-Wallis from the hardness test shows that asymp. 
Sig. 0.000. Moreover, Mann-Whitney Test shows that all 
the formulas had significantly different from each other. 
The tablet friability from all formulas was not too good. 
The requirements were <1%23, while F1 friability was 
6.05%, F2 was 46.25%, and F3 was 1.44%. Necessarily, 
formula development made the tablet more compact and 
had a good binding, so it was not too weak and brittle. 
Wet granulation could be considered to made better 
compactibility because the wet granulation method 
made intragranular bonding (formed during granule 
drying) that did not seem broken during compression, 
the cohesion of particles and binders carrier-binding 
adhesion was a type of bond that contributes to the 
strength of the tablet11. 
The last evaluation was disintegration time. The 
requirement of disintegration time was no more than 15 
minutes18. The result for F1 was 4.33 ± 0.819 s; F2 was 
20.67 ± 2.33 s; and F3 was 33.17 ± 9.43 s. The tablets had so 
fast disintegration time because the friability was weak 
and did not fill the requirements. Necessarily, formula 
development made the tablet more compact and had a 
good binding, not too weak and brittle. The statistical 
analysis with Kruskal-Wallis from disintegration time 
shows that asymp. Sig. 0.001. Furthermore, by Mann-
Whitney Test show that all the formulas had significantly 
different from each other. The overall results of the 
evaluation and characterization were presented in Table 
III. 




F 1 F2 F3 

















1.98±0.44 1.18±0.49 4.28±1.48 
Friability 
(%) 
6.05 46.26 1.44 
Disintegration 
time (s) 
4.33±0.82 20.67±2.34 33.17±9.43 
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The direct compression method had the limitation that 
could ensue segregation and poor compressibility 
compared to the wet granulation method. Differences in 
density between materials could cause segregation24. 
That could also cause the evaluation of hardness and 
friability in this study to be unfavorable. Further method 
development was needed to provide better research, 
such as using the wet granulation method. 
 
CONCLUSION 
In conclusion, Formula F1, F2, and F3 meet the 
requirements for uniformity of weight and size as well as 
disintegration time. The hardness of F3 is better than F1 
and F2. Statistical analysis from weight uniformity, 
hardness, and disintegration time give a significant 
difference—obligatory formulation developing to make 
better tablet's compactibility. 
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